Outsourcing STREAM

  1. An Innovative Approach To Functional Outsourcing 8/27/2025

    The shifting dynamics of clinical research from the current funding dynamic to the increased complexity of drug development, requires a different approach to functional outsourcing to be successful.

  2. Navigating The Unique Attributes Of Psychedelic Drug Development 1/22/2024

    Join our panel of experts for an in-depth review of the FDA's guidance on psychedelic drug development, exploring necessary methodological adaptations for safety, pharmacology, and efficacy.

  3. Successful Implementation Of A Drug-Device Combination Submission 11/21/2025

    Projects including both drug and device components require strategic planning for smooth initiation. Regulatory considerations are the key to success.

  4. Getting Buy-In For Disclosure As A Service 6/3/2020

    Clinical trial disclosure teams often have a tough time convincing upper management on the benefits of Disclosure as a Service. Hear how two sponsors “sold” the idea of outsourcing this function. Watch the short TrialScope interview.

  5. Central eSource: Leveraging Site Technology 2/27/2025

    In this presentation, CRIO founder and co-CEO Raymond Nomizu delves into how sponsors can leverage the electronic source trend among sites through the use of Central eSource.

  6. The Heart Of The Matter: Early Vs. Late QT Prolongation Testing 2/8/2023

    Dr. Beatrice Setnik, Altasciences' Chief Scientific Officer, walks through the differences between early and late QT prolongation testing.

  7. RTSM Software Isn't One-Size-Fits-All, Especially For Small Biotechs 5/13/2026

    Smaller biotech companies often have very different clinical trial needs than large pharmaceutical organizations, and that includes RTSM.

  8. Big Impact With A Personal Touch 1/30/2023

    Transforming lives. Improving human health. Bringing new therapies to life. Altasciences' CRO and CDMO services deliver.

  9. Ensuring Reliable Clinical Trial Material Production 8/27/2024

    Formulation and pharmacy experts share their secrets for completing clinical trials and resolving issues that could impact your drug development program’s timeline.

  10. See How You Can Start Your Early Phase Program 6-9 Weeks Earlier In Canada 3/23/2023

    Vice President of Business Development Lisa Sanford explains whether you need an IND before starting your first-in-human trial in Canada.